Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811316 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis
A NA study, sponsored by Sunstar Americas.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01811316 is a NA study that has completed, run by Sunstar Americas. The registered enrollment target is 62 participants.
The verdict
NCT01811316, a NA study, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term efficacy and safety of lozenges containing probiotics in reducing gingivitis. The primary purpose of this study is to support claims from U.S. instructions for use (IFU) for GUM® PerioBalance®.
Interventions
- OTHER Probiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01811316
The ClinicalTrials.gov registry entry for NCT01811316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sunstar Americas, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Probiotics is the first listed.
NCT01811316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01811316 about?
NCT01811316 is a clinical study titled "A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis". The purpose of this study is to evaluate the long-term efficacy and safety of lozenges containing probiotics in reducing gingivitis. The primary purpose of this study is to support claims from U.S. instructions for use (IFU) for GUM® PerioBalance®.
What is the current status of trial NCT01811316?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01811316?
The interventions under investigation include: Probiotics (OTHER).
Who is sponsoring clinical trial NCT01811316?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.